126 related articles for article (PubMed ID: 30915466)
1. Risk of lung adenocarcinoma from smoking and radiation arises in distinct molecular pathways.
Castelletti N; Kaiser JC; Simonetto C; Furukawa K; Küchenhoff H; Stathopoulos GT
Carcinogenesis; 2019 Oct; 40(10):1240-1250. PubMed ID: 30915466
[TBL] [Abstract][Full Text] [Related]
2. Associations of
Chang JH; Lai TC; Yang PJ; Shih PC; Yang YC; Lee KL; Liu TC; Tsao TC; Yang SF; Chien MH
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126605
[TBL] [Abstract][Full Text] [Related]
3. Radiation and smoking effects on lung cancer incidence by histological types among atomic bomb survivors.
Egawa H; Furukawa K; Preston D; Funamoto S; Yonehara S; Matsuo T; Tokuoka S; Suyama A; Ozasa K; Kodama K; Mabuchi K
Radiat Res; 2012 Sep; 178(3):191-201. PubMed ID: 22862780
[TBL] [Abstract][Full Text] [Related]
4. Lung, Laryngeal and Other Respiratory Cancer Incidence among Japanese Atomic Bomb Survivors: An Updated Analysis from 1958 through 2009.
Cahoon EK; Preston DL; Pierce DA; Grant E; Brenner AV; Mabuchi K; Utada M; Ozasa K
Radiat Res; 2017 May; 187(5):538-548. PubMed ID: 28323575
[TBL] [Abstract][Full Text] [Related]
5. Radiation risks in lung cancer screening programs: a comparison with nuclear industry workers and atomic bomb survivors.
McCunney RJ; Li J
Chest; 2014 Mar; 145(3):618-24. PubMed ID: 24590022
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of decreased GRK6 expression in lung adenocarcinoma.
Yao S; Zhong L; Liu J; Feng J; Bian T; Zhang Q; Chen J; Lv X; Chen J; Liu Y
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2541-2549. PubMed ID: 27601164
[TBL] [Abstract][Full Text] [Related]
7. A five-m6A regulatory gene signature is a prognostic biomarker in lung adenocarcinoma patients.
Wu X; Sheng H; Wang L; Xia P; Wang Y; Yu L; Lv W; Hu J
Aging (Albany NY); 2021 Mar; 13(7):10034-10057. PubMed ID: 33795529
[TBL] [Abstract][Full Text] [Related]
8. Elevated mRNA Levels of AURKA, CDC20 and TPX2 are associated with poor prognosis of smoking related lung adenocarcinoma using bioinformatics analysis.
Zhang MY; Liu XX; Li H; Li R; Liu X; Qu YQ
Int J Med Sci; 2018; 15(14):1676-1685. PubMed ID: 30588191
[No Abstract] [Full Text] [Related]
9. The nonsmokers' and smokers' pathways in lung adenocarcinoma: Histological progression and molecular bases.
Okudela K; Matsumura M; Arai H; Woo T
Cancer Sci; 2021 Sep; 112(9):3411-3418. PubMed ID: 34143937
[TBL] [Abstract][Full Text] [Related]
10. Roles of highly expressed PAICS in lung adenocarcinoma.
Zhou S; Yan Y; Chen X; Wang X; Zeng S; Qian L; Wei J; Yang X; Zhou Y; Gong Z; Xu Z
Gene; 2019 Apr; 692():1-8. PubMed ID: 30641222
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of genomic alterations of lung adenocarcinoma in young never-smokers.
Luo W; Tian P; Wang Y; Xu H; Chen L; Tang C; Shu Y; Zhang S; Wang Z; Zhang J; Zhang L; Jiang L; Liu L; Che G; Guo C; Zhang H; Wang J; Li W
Int J Cancer; 2018 Oct; 143(7):1696-1705. PubMed ID: 29667179
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin drives KRAS-mutant lung adenocarcinoma.
Giopanou I; Kanellakis NI; Giannou AD; Lilis I; Marazioti A; Spella M; Papaleonidopoulos V; Simoes DCM; Zazara DE; Agalioti T; Moschos C; Magkouta S; Kalomenidis I; Panoutsakopoulou V; Lamort AS; Stathopoulos GT; Psallidas I
Carcinogenesis; 2020 Aug; 41(8):1134-1144. PubMed ID: 31740923
[TBL] [Abstract][Full Text] [Related]
13. miR‑30a‑3p suppresses the proliferation and migration of lung adenocarcinoma cells by downregulating CNPY2.
Wang H; Kanmangne D; Li R; Qian Z; Xia X; Wang X; Wang T
Oncol Rep; 2020 Feb; 43(2):646-654. PubMed ID: 31894275
[TBL] [Abstract][Full Text] [Related]
14. Genomic Profiling of Lung Adenocarcinoma in Never-Smokers.
Devarakonda S; Li Y; Martins Rodrigues F; Sankararaman S; Kadara H; Goparaju C; Lanc I; Pepin K; Waqar SN; Morgensztern D; Ward J; Masood A; Fulton R; Fulton L; Gillette MA; Satpathy S; Carr SA; Wistuba I; Pass H; Wilson RK; Ding L; Govindan R
J Clin Oncol; 2021 Nov; 39(33):3747-3758. PubMed ID: 34591593
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer pathogenesis and poor response to therapy were dependent on driver oncogenic mutations.
Sun X; Li K; Zhao R; Sun Y; Xu J; Peng ZY; Song RD; Ren H; Tang SC
Life Sci; 2021 Jan; 265():118797. PubMed ID: 33285162
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of GAD1 overexpression in patients with resected lung adenocarcinoma.
Tsuboi M; Kondo K; Masuda K; Tange S; Kajiura K; Kohmoto T; Takizawa H; Imoto I; Tangoku A
Cancer Med; 2019 Aug; 8(9):4189-4199. PubMed ID: 31207151
[TBL] [Abstract][Full Text] [Related]
17. Lung cancer susceptibility among atomic bomb survivors in relation to CA repeat number polymorphism of epidermal growth factor receptor gene and radiation dose.
Yoshida K; Nakachi K; Imai K; Cologne JB; Niwa Y; Kusunoki Y; Hayashi T
Carcinogenesis; 2009 Dec; 30(12):2037-41. PubMed ID: 19843645
[TBL] [Abstract][Full Text] [Related]
18. Joint effects of radiation and smoking on lung cancer risk among atomic bomb survivors.
Pierce DA; Sharp GB; Mabuchi K
Radiat Res; 2003 Apr; 159(4):511-20. PubMed ID: 12643796
[TBL] [Abstract][Full Text] [Related]
19. Tobacco chemical-induced mouse lung adenocarcinoma cell lines pin the prolactin orthologue proliferin as a lung tumour promoter.
Kanellakis NI; Giannou AD; Pepe MAA; Agalioti T; Zazara DE; Giopanou I; Psallidas I; Spella M; Marazioti A; Arendt KAM; Lamort AS; Champeris Tsaniras S; Taraviras S; Papadaki H; Lilis I; Stathopoulos GT
Carcinogenesis; 2019 Nov; 40(11):1352-1362. PubMed ID: 30828726
[TBL] [Abstract][Full Text] [Related]
20. Indoor radon exposure increases tumor mutation burden in never-smoker patients with lung adenocarcinoma.
Lim SM; Choi JW; Hong MH; Jung D; Lee CY; Park SY; Shim HS; Sheen S; Kwak KI; Kang DR; Cho BC; Kim HR
Lung Cancer; 2019 May; 131():139-146. PubMed ID: 31027691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
